Clinical Research

Bluesky Immunotherapies GmbH

Address
Mariahilfer Strasse 101/1/21, Mariahilf

Sponsor Overview

assignment
2
sponsored trials
science
0
molecules
location_city
3
research centres
public
2
countries
person_search
3
investigators

Specializations

Human papillomavirus-Associated Infections

Bluesky Immunotherapies GmbH focuses on HPV-related infectious disease, with research centered on persistent human papillomavirus infection and its role in disease progression. Its clinical activity includes studies in individuals infected with HPV16 and related viral conditions.

  • HPV16 infection
  • Viral persistence
  • Women with HPV-associated infection

The sponsor’s work in this area is tied to immunotherapeutic strategies aimed at controlling virus-driven disease.

HPV-Associated Precancerous Disease

The company is active in research on precancers linked to HPV infection, reflecting interest in the transition from viral infection to early neoplastic change. This includes conditions arising from oncogenic HPV types that can precede invasive malignancy.

  • Precancerous lesions
  • Oncogenic HPV types
  • Early neoplastic transformation

Research in this domain addresses the clinical setting where prevention of progression is a major therapeutic focus.

HPV-Associated Cancers

Bluesky Immunotherapies GmbH also studies HPV-driven cancers, including malignancies associated with HPV16. Its trial portfolio includes cancer indications where viral antigens are relevant to treatment development.

  • Oropharyngeal squamous cell carcinoma
  • HPV-associated malignancies
  • Virus-related cancer immunotherapy

This area links infectious disease biology with oncology, with emphasis on tumors caused by persistent viral oncogene expression.

Immunotherapy and Clinical Oncology

The sponsor’s research landscape is anchored in immunotherapy for clinical oncology, particularly in diseases driven by HPV antigens. The funded studies reflect interest in immune-based treatment approaches for both established cancer and earlier disease states.

  • Therapeutic cancer immunology
  • Antigen-directed immune treatment
  • Virus-associated oncology

Clinical activity is concentrated in Europe, with recruiting studies across multiple sites in Austria and other participating countries.

Sponsored Trials

Trial Name Country Status
Evaluation of FluBHPVE6E7 and Placebo in Women with Human Papillomavirus Type 16 InfectionSlovakia SlovakiaRecruiting
Phase 1 Evaluation of FluBHPVE6E7 Immunotherapy in HPV16-Associated Oropharyngeal Squamous Cell CarcinomaAustria AustriaRecruiting

Data & Insights

science
Molecule Portfolio
Compounds under investigation
0
Exclusive Molecules
out of 0 total (0% not shared with other sponsors)

This sponsor works with 0 molecules, of which 0 are not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
0%
Return partnership rate
0 of 3 sites collaborated multiple times

This sponsor has worked with 3 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Female Urogenital Diseases and Pregnancy Complications1 trial
    142 other sponsors
  • 2.
    Otorhinolaryngologic Diseases1 trial
    49 other sponsors
  • 3.
    Virus Diseases1 trial
    182 other sponsors

Partnered Research Centres

3 centres
location_city
assignment6
Krankenhaus Der Barmherzigen Schwestern Wien Betriebsgesellschaft mbH
Address
Seilerstaette 4, 4020 Vienna
Learn morearrow_forward
location_city
assignment667
Medical University Of Vienna
Address
Waehringer Guertel 18-20, Alsergrund, 1090 Vienna
Learn morearrow_forward
location_city
assignment89
University Hospital Bratislava
Address
Mickiewiczova 13, Stare Mesto, 811 07 Bratislava
Learn morearrow_forward

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Bluesky Immunotherapies GmbH.

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.